TEBU-BIO ApS: Financial statements 2023
CVR: 10156920
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
TEBU-BIO ApS (CVR 10156920) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,577,642 and a net result of DKK 71,151 compared with DKK 217,508 the year before. That is an increase of 40.7% compared with the year before. Equity in the 2023 report amounted to DKK 462,140. The solvency ratio was 34.1%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,577,642
- Profit/Loss
- DKK 71,151
- Equity
- DKK 462,140
- Total Assets
- DKK 1,356,686
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.6 mio. | 71 t. | 462 t. | 2 |
| 2022 | - | 1.1 mio. | 218 t. | 391 t. | 2 |
| 2021 | - | 1.5 mio. | 761 t. | 923 t. | 1 |
| 2020 | - | 1.2 mio. | 472 t. | 683 t. | 1 |
| 2019 | - | 661 t. | 86 t. | 211 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
TEBU-BIO ApS has published its annual report for 2022. Gross profit came to DKK 1,121,610, and the net result was DKK 217,508.
About TEBU-BIO ApS
TEBU-BIO ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2003. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Donald van Dijk. The company is owned by Tebu bio S.A.. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,064,139 and a net result of DKK -414,038 compared with DKK -60,754 the year before. Equity in the 2025 report amounted to DKK -12,652.